中国药房2017，Vol.28Issue(20)：2768-2771,4.DOI:10.6039/j.issn.1001-0408.2017.20.09
他莫昔芬及其代谢产物血药浓度与ER阳性乳腺癌患者子宫内膜增生的相关性研究
Study on Correlation of Blood Concentrations of Tamoxifen and Its Metabolites with Endometrial Hyper-plasia in ER-positive Breast Cancer Patients
摘要
Abstract
OBJECTIVE:To investigate the correlation of blood concentrations of tamoxifen (TAM) and its metabolites with endometrial hyperplasia in estrogen receptor(ER)-positive breast cancer patients. METHODS:A total of 69 patients with ER-posi-tive breast cancer selected from our hospital during Mar. 2015-Apr. 2016 received TAM (twice a day,one tablet each time) for more than 6 months. According to endometrial thickness,they were divided into abnormal hyperplasia group(40 cases)and normal group(29 cases). The steady state concentrations of TAM and its metabolites [4-OH-tamoxifen(OHT),N-demethylation tamoxifen (DMT),Endoxifen] were determined by HPLC-FLU. The correlation of blood concentration and other factors with endometrial thickness were investigated by Pearson test and multiple regression analysis. RESULTS:The medication time and Endoxifen steady state concentration in abnormal hyperplasia group were both significantly longer or higher than normal group,with statistical signifi-cance (P<0.05). There was no statistical significance in age,BMI,complication and steady state concentrations of TAM,OHT and DMT between 2 groups(P>0.05). The endometrial thickness was positively correlated with Endoxifen steady state concentra-tion and medication time(r=0.447,0.460,P<0.05). Using endometrial thickness(y)as dependent variable,medication time(x1) and Endoxifen steady state concentration(x2)as independent variable,multiple regression analysis was conducted. Multiple regres-sion equation was calculated as follows:y=2.436+0.123x1+0.082x2(F=12.610,r=0.526,P<0.05). CONCLUSIONS:Medication time and Endoxifen steady state concentration may be related to endometrial hyperplasia,which can provide reference for predicting TAM induced endometrial abnormal hyperplasia in ER-positive breast cancer patients.关键词
他莫昔芬/代谢产物/血药浓度/子宫内膜增生/用药时间/相关性Key words
Tamoxifen/Metabolites/Blood concentration/Endometrial hyperplasia/Medication time/Correlation分类
医药卫生引用本文复制引用
朱余兵,赵拯,刘赟心..他莫昔芬及其代谢产物血药浓度与ER阳性乳腺癌患者子宫内膜增生的相关性研究[J].中国药房,2017,28(20):2768-2771,4.基金项目
江苏省药学会奥赛康临床药学立项课题(No.201209) （No.201209）
